The intersection of advanced chemistry and public health is most evident in the production of essential medications. 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid, identified by CAS 376608-65-0, exemplifies this connection by serving as a critical intermediate in the synthesis of Ticagrelor, a vital drug for managing acute coronary syndromes. NINGBO INNO PHARMCHEM CO.,LTD., a leading manufacturer based in China, is committed to bridging this gap by supplying high-purity pharmaceutical intermediates. Our unwavering focus on quality and efficiency ensures that our partners receive the reliable building blocks needed for life-saving therapies.

The precise specifications of CAS 376608-65-0, including its white to off-white powder form and an assay range of 98.0%~102.0%, highlight its suitability for demanding chemical synthesis processes. When pharmaceutical companies choose to buy from NINGBO INNO PHARMCHEM CO.,LTD., they are securing a consistent and high-quality supply chain. Our role as a specialized manufacturer in China allows us to meet global demands with competitive pricing and timely deliveries, making us an essential partner in drug development.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting the healthcare industry by providing the fundamental chemical components required for advanced treatments. Our expertise in pharmaceutical intermediates means we can facilitate the production of vital cardiovascular drugs, contributing to improved patient outcomes worldwide. For businesses seeking a reliable supplier for essential chemical synthesis ingredients, NINGBO INNO PHARMCHEM CO.,LTD. offers quality, expertise, and a commitment to excellence.